These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 26379825)
1. Biomarkers of head and neck cancer, tools or a gordian knot? Lampri ES; Chondrogiannis G; Ioachim E; Varouktsi A; Mitselou A; Galani A; Briassoulis E; Kanavaros P; Galani V Int J Clin Exp Med; 2015; 8(7):10340-57. PubMed ID: 26379825 [TBL] [Abstract][Full Text] [Related]
2. Exploring biomarkers in head and neck cancer. Langer CJ Cancer; 2012 Aug; 118(16):3882-92. PubMed ID: 22281752 [TBL] [Abstract][Full Text] [Related]
3. Integration of biomarkers including molecular targeted therapies in head and neck cancer. Williams MD Head Neck Pathol; 2010 Mar; 4(1):62-9. PubMed ID: 20237991 [TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. McKaig RG; Baric RS; Olshan AF Head Neck; 1998 May; 20(3):250-65. PubMed ID: 9570632 [TBL] [Abstract][Full Text] [Related]
5. Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas. Menéndez ST; Rodrigo JP; Alvarez-Teijeiro S; Villaronga MÁ; Allonca E; Vallina A; Astudillo A; Barros F; Suárez C; García-Pedrero JM Mod Pathol; 2012 Aug; 25(8):1069-78. PubMed ID: 22460808 [TBL] [Abstract][Full Text] [Related]
6. De-Escalated Therapy and Early Treatment of Recurrences in HPV-Associated Head and Neck Cancer: The Potential for Biomarkers to Revolutionize Personalized Therapy. Yarbrough WG; Schrank TP; Burtness BA; Issaeva N Viruses; 2024 Mar; 16(4):. PubMed ID: 38675879 [TBL] [Abstract][Full Text] [Related]
7. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias. Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203 [TBL] [Abstract][Full Text] [Related]
8. Is biomarker research advancing in the era of personalized medicine for head and neck cancer? Yokota T Int J Clin Oncol; 2014 Apr; 19(2):211-9. PubMed ID: 24442754 [TBL] [Abstract][Full Text] [Related]
9. [Subtype analysis and clinical significance of HPV infection in laryngeal squamous cell carcinoma and precancerous lesions]. Guan L; Sun N; Sun G; Fang Q; Meng Y; Zhao X; Meng L Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 29(17):1549-52. PubMed ID: 26647542 [TBL] [Abstract][Full Text] [Related]
10. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer]. Wittekindt C; Wagner S; Mayer CS; Klußmann JP Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913 [TBL] [Abstract][Full Text] [Related]
11. Autofluorescence videoendoscopy for photodiagnosis of head and neck squamous cell carcinoma. Paczona R; Temam S; Janot F; Marandas P; Luboinski B Eur Arch Otorhinolaryngol; 2003 Nov; 260(10):544-8. PubMed ID: 12774235 [TBL] [Abstract][Full Text] [Related]
12. Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia. Ranganath K; Feng AL; Franco RA; Varvares MA; Faquin WC; Naunheim MR; Saladi SV Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428690 [TBL] [Abstract][Full Text] [Related]
13. Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments. Jayawickrama SM; Ranaweera PM; Pradeep RGGR; Jayasinghe YA; Senevirathna K; Hilmi AJ; Rajapakse RMG; Kanmodi KK; Jayasinghe RD Cancer Rep (Hoboken); 2024 Mar; 7(3):e2045. PubMed ID: 38522008 [TBL] [Abstract][Full Text] [Related]
14. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1). Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857 [TBL] [Abstract][Full Text] [Related]
16. The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma. Haring CT; Dermody SM; Yalamanchi P; Kang SY; Old MO; Chad Brenner J; Spector ME; Rocco JW Oral Oncol; 2022 Mar; 126():105776. PubMed ID: 35183912 [TBL] [Abstract][Full Text] [Related]
17. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer". Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111 [TBL] [Abstract][Full Text] [Related]
18. Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing. Chung CH; Guthrie VB; Masica DL; Tokheim C; Kang H; Richmon J; Agrawal N; Fakhry C; Quon H; Subramaniam RM; Zuo Z; Seiwert T; Chalmers ZR; Frampton GM; Ali SM; Yelensky R; Stephens PJ; Miller VA; Karchin R; Bishop JA Ann Oncol; 2015 Jun; 26(6):1216-1223. PubMed ID: 25712460 [TBL] [Abstract][Full Text] [Related]
19. Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives. Rosenberg AJ; Vokes EE Oncologist; 2021 Jan; 26(1):40-48. PubMed ID: 32864799 [TBL] [Abstract][Full Text] [Related]
20. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma]. Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]